Inactivation of macrophage nitric oxide synthase activity by NG-Methyl-L-arginine by Olken, Norman M. et al.
Vol. 177, No. 2, 1991 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
June 14, 1991 Pages 828-833 
INACTIVATION OF MACROPHAGE NITRIC OXIDE SYNTHASE ACTIVITY BY 
NG-METHYL-L-ARGININE 
Norman M. Olkens, Kristin M. Ruschefl, Michael K. RichardsI, and Michael A. Marletta§fl* 
Interdepartmental Program in Medicinal Chemistry~, Col!ege of Pharmacy and the Department of 
Biological ChemistryI, School of Medicine, University of Michigan, Ann Arbor, MI 48 109- 1065 
Received April 26, 1991 
Summary. .N=O synthase catalyzes the oxidation of one of the two chemically equivalent guanido 
nitrogens of L-arginine to nitric oxide (.N=O). NG-Methyl-L-arginine has been previously 
characterized as a potent competitive inhibitor of both major types of .N=O synthases. Initial rate 
kinetics were performed with a spectrophotometric assay based on the oxidation of oxy- to 
methemoglobin by .N=O. NG-Methyl-L-arginine was a competitive inhibitor of .N=O synthase 
activity derived from activated murine macrophages with a Ki of 6.2 PM . When the enzyme was 
pre-incubated in the presence of the required cofactors NADPH and tetrahydrobiopterin, time- and 
concentration-dependent irreversible inactivation of the activity was observed. At 37’ C the kinact 
was 0.050 mint. This inactivation process exhibited substrate protection, saturation kinetics and 
required the cofactors necessary for enzymatic turnover. These data indicate that NG-methyl-L- 
arginine acts as a mechanism-based enzyme inactivator of murine macrophage .N=O synthase. 
0 1991 ACxkrnlC mess, Inc. 
Many cells are now known to synthesize nitric oxide (.N=O) by the oxidation of one of the 
two chemically equivalent guanido nitrogens of L-arginine (1). Two types of .N=O synthases have 
been identified: a constitutively expressed Ca2+/calmodulin-dependent form isolated from rat 
cerebella (2) and identified in vascular endothelial cells (3); and a cytokine inducible, calmodulin- 
independent form isolated from neutrophils (4) and macrophages (5), and identified in a wide variety 
of other cell types (6). Both forms of .N=O synthase utilize the co-substrates L-arginine and 
molecular oxygen, and require NADPH. Tetrahydrobiopterin (BH4) has been shown to be a 
required cofactor for .N=O synthase activity derived from the supernatant of activated murine 
macrophages (7, 8). 
The inducible form of .N=O synthase isolated from macrophages and neutrophils is 
expressed in response to various cytokines, such as interferon-y, tumor necrosis factor-a and 
bacterial lipopolysaccharide. Upon induction, these cells generate .N=O continuously for as long as 
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72 hours (9). This .N=O clearly serves to augment cell-mediated immunity. Specifically, .N=O has 
been shown to cause a pronounced loss of intracellular iron and the inhibition of the iron-sulfur 
protein aconitase in LlO hepatoma cells (10). The iron-sulfur protein ribonucleotide reductase also 
appears to be an important target for .N=O (11). Additionally, the intracellular destruction of 
L&mania (12) and Toxoplasma go&ii (13) by macrophages has been closely correlated with ,N=O 
generation. 
NG-Methyl-L-arginine (L-NMA) was initially reported by Hibbs and colleagues to be a 
potent inhibitor of macrophage nitrite generation (14). In fact, L-NMA has been reported to be a 
competitive inhibitor of both forms of the .N=O synthase (15, 16). We noted a time-dependent loss 
of .N=O synthase activity after pre-incubation with L-NMA, NADPH and B&. This inactivation 
has now been characterized under initial rate conditions by measuring .N=O generation directly with 
a spectrophotometric assay based on the rapid and quantitative oxidation of oxy- to methemoglobin 
(metHb) by .N=O (17, 18). L-NMA produces a time- and concentration-dependent irreversible loss 
of .N=O synthase activity from activated murine macrophages. This inactivation has all the markings 
of mechanism-based enzyme inactivation: turnover-dependence, saturation kinetics and substrate 
protection. 
Materials and Methods 
Analytical Methods. Assays for enzyme activity were carried out in disposable 
semimicro cuvettes (Bio-Rad), on a Perkin-Elmer 553 spectrophotometer equipped with a Perkin- 
Elmer RlOO chart recorder. A reference cuvette was charged with 2 j.tM oxyhemoglobin (oxyHb) 
in 15 mM HEPES (pH 7.4), in a final volume of 500 ~1. A typical sample assay contained 2 mM 
L-arginine, 1 mM Mg2+, 167 PM DTT, 100 PM NADPH, 12 yM BHq, and 2 J,~M oxyHb in 15 
mM HEPES (pH 7.4), in a final volume of 500 ~1. All assays were initiated with protein. The 
HEPES buffer was heated to 37’ C prior to use, and the cell holders inside the spectrophotometer 
were kept at 37” C with a Thermomix 1460 thermocirulator. Enzyme activity is directly 
proportional to the increase in absorbance at 401 nm over time. Protein concentration of desalted 
supematant was determined with the Bradford Assay (Bio-Rad) using bovine serum albumin as the 
standard (19). 
Reagents. NG-Methyl-L-arginine, acetate salt (L-NMA) was purchased from 
Calbiochem. L-arginine, human ferrous hemoglobin A,, NADPH, DTT, HEPES, and magnesium 
acetate were purchased from Sigma. (6R)-5,6,7,8-Tetrahydro-L-biopterin (BHq), and 7,8- 
dihydro-L-biopterin (BH2) were purchased from Dr. B. Schircks Laboratories, Jona, Switzerland. 
Enzyme Preparation. Macrophage cytosol was prepared from the murine macrophage 
cell line RAW 264.7 and desalted as described previously (7). A typical preparation of desalted 
supernatent had a specific activity of 300 nmoles .N=O/mg protein/hour as determined with the 
hemoglobin assay. 
Competitive Inhibition of Murine Macrophage .N=O Synthase by L-NMA. 
Desalted supernatant (60 ~1) was added to an assay cuvette containing 50 J.~M L-arginine, 1 mM 
Mg2+, 167 PM DTT, 100 pM NADPH, 12 PM Bh, 2 J.~M oxyHb, and 0,5, 10,25, or 50 PM 
L-NMA in 15 mM HEPES (pH 7.4) at 37’ C, in a final volume of 500 ~1. 
Time- and Concentration-Dependent Inactivation of Murine Macrophage 
-N=O Synthase by L-NMA. Desalted supematent (300 ~1) (typically about 500 pg of protein) 
was added to a pre-incubation mixture to produce final concentrations of 1 mM Mg2+, 833 /.tM 
D’lT, 100 J,~M NADPH, 60 PM BH4 and L-NMA in 15 mM HEPES (pH 7.4), in a final volume 
of 600 ~.tl. Concentrations of L-NMA in the pre-incubation mixture were 1.5, 3.0, 5, 10, 25 or 50 
PM. After the addition of enzyme, an initial 100 ~1 aliquot was removed and assayed for activity 
as described below. The pre-incubation mixture was then placed in a 37’ C water bath. Aliquots 
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(typically 100 @) were removed and assayed for activity after 15, 30, 45, 60 and 75 minutes. 
Each aliquot was added to a cuvette containing cofactors and oxyHb to produce a final volume of 
500 ~1 and final concentrations of 2 mM L-arginine, 1 mM M$+, 167 pM DTT, 100 pM 
NADPH, 12 FM BI& and 2 PM oxyHb in 15 mM HEPES (pH 7.4) at 37” C. 
Irreversibilty of -N=O Synthase Inactivation. A pre-incubation was performed at 
37’ C as described above in the presence of 25 pM L-NMA for 45 minutes. At this time the 
remaining enzyme activity was measured, the pre-incubation was removed from the 37” C 
waterbath (the residual activity is unstable at 37’ C), placed at room temperature, and 5 mM L- 
arginine was added. The activity was assayed at 30 minutes intervals for 2.5 hours, as described 
above. 
Cofactor-Dependence of *N=O Synthase Inactivation. Pre-incubations and 
activity assays were run at 22’ C in the presence of 25 pM L-NMA, but otherwise as described 
above. BH2 and NADP+ concentrations were 60 and 100 PM, respectively. 
Results 
Time- and Concentration-Dependent Inactivation of Murine Macrophage .N=O Synthase by 
L-NMA. Figure IA shows the time- and concentration-dependent inhibition of murine 
macrophage .N=O synthase by 1.5,5 and 25 pM L-NMA. The control experiment illustrates the 
relatively small loss in activity which occurs when the enzyme is pre-incubated with 1 mM Mg2+, 
833 pM DTT, 100 FM NADPH and 60 PM BHq in the absence of substrate. In the presence of L- 
arginine, there is typically almost no loss of activity measured under these conditions after 1 hour 
(not shown). From a Kitz and Wilson replot (20) of l/kobs vs. l/[I] (figure 2) a kinact of 0.050 
min-l and a KI of 4.2 PM were obtained. 
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Figure 1A. Time- and Concentration-Dependent Inactivation of Murine 
Macrophage *N=O Synthase by L-NMA. The vertical axis is the natural log of the ratio of 
enzyme activity remaining at the end of the pre-incubation time to the enzyme activity measured 
after no pre-incubation. All 
(0) uM L-NMA, 1 mM Mg f 
re-incubations were done at 37’ C with 0 (0), 1.5 (I), 5 ( A ) or 25 
+, 833 uM DTZT, 100 uM NADPH, and 60 uM B&. At 15 minute 
intervals the remaining activity was assayed as described in Methods. 
Figure 1B. Concentration-Dependent Substrate Protection by L-Arginine. 
L-arginine at 100 ( A ) or 500 (m) pM concentrations was pre-incubated at 37’ C with 25 uM L- 
NMA and 1 mM Mg*+, 833 l.tM DTT, 100 uM NADPH and 60 uM B&t. The control activity (0) 
represents apre-incubation mixture of enzyme and 1 mM Mg*+, 833 uM D’IT, 100 yM NADPH 
and 60 uM B& without either substrate or inhibitor. Shown for comparison is a pre-incubation 
with 25 pM L-NMA (0) and no L-arginine run under the same conditions as above. 
Figure 2. Kitz and Wilson Replot. The inactivation kinetics shown in figure 1A 
were replotted according to Kitz and Wilson (20). This graph includes the data from figure 1A as 
well as that obtained from inactivation experiments with 3, 10 and 50 PM L-NMA (not shown). 
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Figure 3. Cofactor-Dependence of .N=O Synthase Inactivation by L-NMA. 
Pre-incubation at 22’ C with 25 yM L-NMA in the presence of 1 mM Mg2+, 833 PM D’IT, 100 
PM NADPH and 60 PM BHq (0) or 1 mM Mg 2+, 100 PM NADPt and 60 PM BH2 ( A ). Each 
pre-incubation mixture also contained 300 ~1 of protein in a final volume of 600 ~1 of 15 mM 
HEPES (pH 7.4). 
Irreversibilty and Saturability of .N=O Synthase Inactivation. Since enzyme activity was 
determined with a continuous spectrophotometric assay in the presence of 2 mM L-arginine (K, 
7.4 PM in this system), rapid reactivation of the .N=O synthase (following inactivation by L- 
NMA) would have been apparent. However, even after 15-20 minutes of observation no evidence 
for any increase in the velocity of the enzymatic reaction was noted. In fact, no restoration of 
enzyme activity was detected when enzyme inactivated over 45 minutes by 25 PM L-NMA was 
incubated at room temperature (22“ C) with 5 mM L-arginine over 2.5 hours. The inactivation 
process was shown to be saturable as well, with concentrations of L-NMA greater than 25 PM 
resulting in very small increases in the rate of enzyme inactivation (not shown). 
Substrate Protection. Figure 1B shows the concentration-dependent substrate protection 
afforded by 100 and 500 PM L-arginine when pre-incubated at 37’ C with 1 mM Mg2+, 833 PM 
DlT, 100 PM NADPH, 60 j&i BHq and 25 PM L-NMA. 
Cofactor-Dependence of .N=O Synthase Inactivation. .N=O synthase activity requires 
NADPH (21), and, in fact, is quite unstable at 37’ C in the absence of either NADPH or BH4. 
Therefore it was impossible to demonstrate the retention of enzyme activity following pre- 
incubation of the enzyme and L-NMA in the absence of one of these cofactors at 37’ C. At 4’ C a 
pre-incubation with NADPH, B& and 25 PM L-NMA showed no significant loss of activity over 
several hours (not shown). The problem of demonstrating cofactor-dependent loss of .N=O 
synthase activity with L-NMA was solved by pre-incubating the enzyme with reduced (NADPH 
and BQ) or oxidized (NADP+ and B&) cofactors at room temperature (22” C). Figure 3 shows 
the time-dependent loss of enzyme activity for a pre-incubation carried out at 22’ C with 100 PM 
NADPH, 60 FM BHJ, and 25 PM L-NMA. The k&s is 0.013 min-l, only 30% that observed at 
37O c. 
A pre-incubation carried out at 22’ C with the oxidized forms (100 PM NADP+ and 60 @4 
BH2) of the required cofactors and 25 PM L-NMA also initially demonstrates some enzyme 
inactivation, which slows after 30 minutes and ceases after about 90 minutes (Figure 3). Although 
some enzyme inactivation was evident when NADP+ and BH2 were used as cofactors, this may 
831 
Vol. 177, No. 2, 1991 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
have been due to the in situ reduction of NADP+ to NADPH (7). Additionally, the pterin appears 
to be tightly bound (unpublished observations). For these reasons it was impossible to abolish 
enzymatic turnover. In fact, a low but detectable initial velocity of .N=O generation was noted 
with protein, oxidized cofactors, and L-arginine at 22’ C. 
Discussion 
In agreement with the initial observations, L-NMA was found to be a relatively potent 
competitive inhibitor of the .N=O synthase activity in activated murine macrophages. A Ki of 6.2 
PM was derived from a Dixon plot (not shown). For comparison, the Kin of L-arginine under 
these conditions was 7.4 l.tM. As described above and shown in figure lA, pre-incubation of 
enzyme with L-NMA, NADPH, and BH4 at 37” C results in a time- and concentration-dependent 
loss of .N=O synthase activity. From a Kitz and Wilson replot (20) of l/kot,s vs. l/[I] (figure 2) a 
kinact of 0.050 min-1 and a Kt of 4.2 PM were obtained. In addition, as shown in figure 1B the 
substrate L-arginine protects against this inactivation in a concentration-dependent fashion 
suggesting that the inactivation process occurs at or near the active-site. 
The inactivation of .N=O synthase is apparently irreversible. That is, enzyme inactivated 
during a 45 minutes pre-incubation by 25 PM L-NMA was then incubated at room temperature 
with 5 mM L-arginine for 2.5 hours. Aliquots removed at 30 minute intervals failed to 
demonstrate enzyme reactivation, The inactivation process was also shown to be saturable; 
concentrations of L-NMA greater than 25 PM resulted in very small increases in the rate of enzyme 
inactivation (not shown). 
The enzyme is unstable at 37” C in the absence of either BII4 or NADPH, preventing the 
study of turnover-dependent inactivation at that temperature. Time-dependent inactivation of .N-+ 
synthase activity also occurs at 22” C when the pre-incubation reaction contained NADPH, BH4, 
and 25 /.tM L-NMA (Figure 3). In contrast, also at 22’ C, a pre-incubation reaction which 
contained NADP+, BH2 and 25 l.tM L-NMA did not demonstrate a time-dependent loss of .N=O 
synthase activity over 2.5 hours (Figure 3). In this way conditions were found which supported 
enzymatic turnover in the presence of the required reduced cofactors, and which maintained 
enzyme stability in their absence. 
The inactivation of the enzyme most likely arises from one of three mechanisms 
(Scheme 1). One possibility is that L-NMA proceeds down the normal reaction pathway 
generating an N-hydroxylated intermediate that is tightly bound. Thus, L-NMA could be 
converted to NG-hydroxy-NG-methyl-L-arginine, a mimic of NG, NG-dihydroxy-L-arginine, a 
proposed reaction intermediate (21). An alternative, covalent mechanism is the formation at the 
active site of a chemically reactive species such as a carbon-centered free radical or an imine-type 
Michael acceptor. Thirdly, peroxide formation uncoupled from substrate hydroxylation at the 
active site is a well-characterized means by which oxygenases like phenylalanine hydroxylase auto- 
inactivate in the presence of some substrate analogs (22). We have synthesized [3H]-L-NMA and 
are investigating the actual molecular nature of the inactivation by L-NMA herein reported. In 
addition, we are extending these findings to a number of arginine analogs. 
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carbanolamine imine 
Scheme 1. Two Mechanisms for Inactivation of *N=O Synthase by L-NMA. 
N-hydroxylation produces NG-hydrox -NG-methyl-L-arginine, a potential tight-binding analog of 
a postulated reaction intermediate, N dlG’ ,N -dlhydroxy-L-arginine. Alternatively, C-hydroxylation 
produces a carbanolamine which dehydrates to yield a Michael acceptor imine-like moiety. This, in 
turn, could hydrolyze to yield formaldehyde and L-arginine. 
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